Effectiveness of inhibition of cholesteryl ester transfer protein by JTT-705 in combination with pravastatin in type II dyslipidemia

American Journal of Cardiology

Volumn 95, Issue 9, 2005, Pages 1085-1088

  Kuivenhoven, Jan Albert ^b   De Grooth, Greetje J ^b   Kawamura, Hitoshi ^b   Klerkx, Anke H ^b   Wilhelm, Francois ^b   Trip, Mieke D ^b   Kastelein, John J P ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

2 METHYLPROPANETHIOIC ACID S [2 [1 (2 ETHYLBUTYL)CYCLOHEXYLCARBOXAMIDO]PHENYL] ESTER; CHOLESTEROL ESTER TRANSFER PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; PRAVASTATIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CHOLELITHIASIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG SCREENING; DRUG TOLERABILITY; DRUG USE; DYSLIPIDEMIA; FATIGUE; FEMALE; GASTROENTERITIS; HEADACHE; HUMAN; INFECTION; INFESTATION; INFLUENZA; INHIBITION KINETICS; MAJOR CLINICAL STUDY; MALE; MUSCULOSKELETAL DISEASE; MYALGIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT DISEASE; SIDE EFFECT; VASCULAR DISEASE;

EID: 17444372760     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2004.12.064     Document Type: Article

References (10)

1. G.J. de Grooth, J.A. Kuivenhoven, A.F. Stalenhoef, J. de Graaf, A.H. Zwinderman, J.L. Posma, A. van Tol, J.J. Kastelein Efficacy and safety of a novel cholesteryl ester transfer protein inhibitor, JTT-705, in humans: a randomized phase II dose-response study Circulation 105 2002 2159 2165
2. M.E. Brousseau, E.J. Schaefer, M.L. Wolfe, L.T. Bloedon, A.G. Digenio, R.W. Clark, J.P. Mancuso, D.J. Rader Effects of an inhibitor of cholesteryl ester transfer protein on HDL cholesterol N Engl J Med 350 2004 1505 1515
3. R.W. Clark, T.A. Sutfin, R.B. Ruggeri, A.T. Willauer, E.D. Sugarman, G. Magnus-Aryitey, P.G. Cosgrove, T.M. Sand, R.T. Wester, J.A. Williams Raising high-density lipoprotein in humans through inhibition of cholesteryl ester transfer protein: an initial multidose study of torcetrapib Arterioscler Thromb Vasc Biol 24 2004 1 9
4. P.J. Barter, H.B. Brewer Jr, M.J. Chapman, C.H. Hennekens, D.J. Rader, A.R. Tall Cholesteryl ester transfer protein: a novel target for raising HDL and inhibiting atherosclerosis Arterioscler Thromb Vasc Biol 23 2003 160 167
5. G.R. Warnick, J.J. Albers A comprehensive evaluation of the heparin-manganese precipitation procedure for estimating high density lipoprotein cholesterol J Lipid Res 19 1978 65 76
6. W.T. Friedewald, R.I. Levy, D.S. Fredrickson Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge Clin Chem 18 1972 499 502
7. H. Kato, T. Nakanishi, H. Arai, H.I. Nishida, T. Nishida Purification, microheterogeneity, and stability of human lipid transfer protein J Biol Chem 264 1989 4082 4087
8. S. Sawada, M. Sugano, N. Makino, H. Okamoto, K. Tsuchida Secretion of pre beta HDL increases with the suppression of cholesteryl ester transfer protein in HepG2 cells Atherosclerosis 146 1999 291 298
9. Illingworth DR. Achievement of low-density lipoprotein cholesterol goals: new strategies to address new guidelines. Cardiol Clin 2003;21:363-375.
10. M. Sugano, N. Makino, S. Sawada, S. Otsuka, M. Watanabe, H. Okamoto, M. Kamada, A. Mizushima Effect of antisense oligonucleotides against cholesteryl ester transfer protein on the development of atherosclerosis in cholesterol-fed rabbits J Biol Chem 273 1998 5033 5036